What type of study is this?

This is a Cross-Sectional Study study.

What question did this study set out to answer?

To characterize the management of neuroendocrine tumors among Mexican oncologists and assess resource availability.

January 14, 2026Journal of Clinical Oncology0 citations

Patterns of care and access to resources in neuroendocrine tumors (NETs): A cross-sectional survey among Mexican oncologists.

JOJ Careaga OlivaresMexican Social Security Institute JHJorge Humberto Hernandez-Felix MMM. Meneses-MedinaInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Key Points

To characterize the management of neuroendocrine tumors among Mexican oncologists and assess resource availability.
Nationwide cross-sectional survey conducted among medical oncologists in Mexico
Anonymous responses collected via REDCap
Statistical analyses performed using SPSS v25
Survey included 100 oncologists with varying practice settings
Access to therapies and imaging was significantly better in the private sector
Marked disparities in available diagnostic tools and multidisciplinary resources were reported

Abstract

630 Background: NETs are uncommon malignancies whose optimal management depends on timely diagnosis, access to specialised imaging and therapies, and multidisciplinary collaboration. Data on how NETs are managed in middle-income countries are scarce. We aimed to characterise local practice patterns, resource availability and professional perceptions among oncologists in Mexico. Methods: Between May-Aug 2025, we conducted a nationwide, anonymous, cross-sectional survey of medical oncologists registered with the Mexican Society of Oncology (SMEO). Each physician received an invitation with a REDCap link. Responses were exported from REDCap. The statistical analysis was performed using SPSS v25. Results: One-hundred oncologists responded to the survey; 28 worked exclusively in public practice, 28 exclusively in private and 43 in both settings. Demographic characteristics: 54 % men, age range 30–40 years in 71%; 41–50 years in 17%, and over 50 years in 12%. Geographic distribution: 18% practiced in Mexico City, 12% in Nuevo León, 5% in Jalisco, and the remaining were dispersed across other states. Data were analyzed according to practice setting independently (N=142 answers), see table 1 for results of practice patterns, diagnostic resources, therapy availability. Conclusions: This study reveals marked disparities in NET care in Mexico. Access to advanced imaging and targeted therapies is concentrated in the private sector, whereas many public-sector oncologists lack basic diagnostic tools and multidisciplinary support. The identification of distinct practice profiles highlights the need for targeted interventions to reduce gaps and to develop national guidelines tailored to resource-limited settings. Variable Total N=142 (%) Private n=71 (%) Public n=71 (%) p-value* Nuclear imaging Octreoscan 75 (52.8) 38 (53.5) 37 (52.1) 1.00 NET-PET 57 (40.1) 43 (60.6) 14 (19.7) <0.0001 No nuclear imaging studies 19 (13.4) 10 (14.1) 9 (12.7) 1.00 Systemic therapies SSA 104 (73.2) 60 (84.5) 44 (62.0) 0.004 Everolimus 62 (43.7) 38 (53.5) 24 (33.8) 0.027 Sunitinib 58 (40.8) 40 (56.3) 18 (25.4) 0.0003 Lenvatinib 60 (42.3) 42 (59.2) 18 (25.4) <0.0001 Cabozantinib 41 (28.9) 32 (45.1) 9 (12.7) <0.0001 PRRT 29 (20.4) 16 (22.5) 13 (18.3) 0.68 Chemotherapy 102 (71.8) 57 (80.3) 45 (63.4) 0.039 Multidisciplinary resources Tumor board not available 79 (55.6) 44 (62) 35 (49.3) 0.19 <jats:td colspan="1" conte

问 AI

Bookmark

View Full Paper